search icon

    Market Snapshot

    • S&P Futures

      4,132.75

    • Dow Futures

      32,794

    • Nasdaq Futures

      13,103.75

    blog search icon

    Seelos Therapeutics, Inc.

    (NASDAQ:SEEL)

    $0.90

    -$0.1

    -9.97%

    Seelos Therapeutics, Inc. Chart

    SEEL Stock Price Today

    Seelos Therapeutics, Inc. (SEEL) stock declined over -9.97% intraday to trade at $0.9002 a share on NASDAQ. The stock opened with a loss of -4.23% at $0.97 and touched an intraday high of $1.04, falling -9.98% against the last close of $1. The stock went to a low of $0.9 during the session.

    Stock Snapshot

    $1

    Prev. Close

    92.9 Million

    Market Cap

    $0.9

    Day Low

    $0.97

    Open

    105.53 Million

    Number of Shares

    $1.04

    Day High

    -

    P/E ratio

    -0.60

    EPS (TTM)

    0.58

    Cash Flow per Share

    6.48

    Free Float in %

    0.71

    Book Value

    1,218,314

    Volume

    Seelos Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$0.97$1.04$0.9$0.91,184,558
    2022-08-05$0.94$1.03$0.94$1922,800
    2022-08-04$0.91$1$0.9$0.97692,700
    2022-08-03$0.86$0.92$0.86$0.9416,100
    2022-08-02$0.88$0.89$0.85$0.87369,300
    2022-08-01$0.84$0.9$0.84$0.85366,000
    2022-07-29$0.88$0.89$0.84$0.84260,100
    2022-07-28$0.87$0.9$0.85$0.87383,600
    2022-07-27$0.89$0.89$0.83$0.84495,600
    2022-07-26$0.89$0.89$0.87$0.88327,200

    Contact Details

    300 Park Avenue
    2nd Floor
    New York, NY 10022
    United States

    Webiste:SEEL

    646 293 2100

    Company Information

    Employees-

    Beta2.46

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.

    Frequently Asked Questions

    icon

    What is the current Seelos Therapeutics, Inc. (SEEL) stock price?

    Seelos Therapeutics, Inc. (NASDAQ: SEEL) stock price is $0.9002 as of the last check on Monday, August 8. During the trading session, SEEL stock reached the peak price of $1.04 while $0.9 was the lowest point it dropped to.

    icon

    SEEL's industry and sector of operation?

    The NASDAQ listed SEEL is part of Pharmaceuticals industry that operates in the broader Health Care sector. Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders.

    icon

    Who are the executives of SEEL?

    Dr. Raj Mehra J.D., Ph.D.
    Founder, Chairman, CEO & Pres
    Mr. Michael J. Golembiewski
    Chief Financial Officer
    Ms. Kimberly Farrand
    Sr. Director of Clinical Devel. & Operations
    Mr. Anthony Marciano
    Chief Communications Officer

    icon

    What is the SEEL stock price today?

    SEEL stock traded closed the last session at $0.9, which is -$0.09970000000000001 or -9.970997099709972% lower than its previous close of $1. SEEL's current trading price is 87.42% lower than its 52-week high of $2.79 where as its distance from 52-week low of 0.48% is -67.73%.

    icon

    How many employees does SEEL have?

    Number of SEEL employees currently stands at -. SEEL operates from 300 Park Avenue, 2nd Floor, New York, NY 10022, United States.

    icon

    Link for SEEL official website?

    Official Webiste of $SEEL is: https://seelostherapeutics.com

    icon

    How do I contact SEEL?

    SEEL could be contacted at SEEL operates from 300 Park Avenue, 2nd Floor, New York, NY 10022, United States, or at phone #646 293 2100 and can also be accessed through its website.

    icon

    How many shares of SEEL are traded daily?

    SEEL stock volume for the day was 1,218,314 shares while in the previous session number of SEEL shares traded was 1,184,558 . The average number of SEEL shares traded daily for last 3 months was 1.2 Million.

    icon

    How much did SEEL change today?

    The percentage change in SEEL stock occurred in the recent session was -9.970997099709972% while the dollar amount for the price change in SEEL stock was -$0.09970000000000001.

    icon

    What price range SEEL stock been trading in?

    In the recent session, the day high for SEEL stock was $1.04 while the low for SEEL stock touched on the day was $0.9.

    icon

    What is the market cap of SEEL currently?

    The market value of SEEL currently stands at 92.9 Million with its latest stock price at $0.9002 and 105.53 Million of its shares outstanding.